ExploreWatchlistsPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Inventories

Sumitomo Pharma Co., Ltd. (4506)

Market cap
¥877B
P/E ratio
9.5x
Sumitomo Pharma manufactures and sells prescription pharmaceuticals globally, with specialized focus on regenerative and cell medicine through joint ventures.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndInventories (Million JPY)YoY (%)
Mar 31, 202594,222-18.32%
Mar 31, 2024115,350+22.19%
Mar 31, 202394,405-4.66%
Mar 31, 202299,021+7.38%
Mar 31, 202192,215+16.19%
Mar 31, 202079,368+18.66%
Mar 31, 201966,889+95.64%
Mar 31, 201834,190-37.81%
Mar 31, 201754,973+14.29%
Mar 31, 201648,100-5.22%
Mar 31, 201550,749

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat